Navigation Links
Synthetech Earns National Recognition for Performance Improvement Program
Date:12/18/2007

ALBANY, Ore., Dec. 18 /PRNewswire-FirstCall/ -- Synthetech, Inc. (OTC Bulletin Board: NZYM) has earned four 2007 Silver Performance Improvement Awards for their outstanding accomplishments in environmental, health, safety and security (EHS&S) performance. The Silver Awards are presented by the Synthetic Organic Chemical Manufacturers Association (SOCMA) and sponsored by ChemStewards, SOCMA's EHS&S initiative. The awards are highly regarded and demonstrate Synthetech's level of commitment and progress to the principles of EHS&S that puts them in a class above their peers.

In winning four Silver Awards, Synthetech is receiving more awards than any other facility. "Synthetech should be commended for their work," said Joe Acker, SOCMA president. "Our panel of judges found them to be an impressive example for the rest of the industry. Synthetech shows they are committed to performance excellence and to improving the quality of life in their community. We hope that other companies will see the progress Synthetech has made and will use them as an example for their own programs. We applaud Synthetech and hope they continue these efforts."

"Our commitment to environmental, health, safety, and security is driven by our culture and these SOCMA awards provide visibility for actions which are standard procedure at Synthetech every day," said Synthetech President and COO, Dr. Greg Hahn. "We are especially proud of the on-going hard work by our employees to ensure a safe and secure environment for our facilities and community."

SOCMA, the leading international trade association representing the custom and specialty chemical industry, recognized Synthetech at its Annual Dinner during a special awards ceremony on December 10th in New York City.

As part of the Awards process, Synthetech outlined its efforts to:

-- Reduce waste;

-- Use resources as efficiently as possible;

-- Engage stakeholders and their community continually and effectively;

-- Promote the concept of product stewardship throughout a product's

lifecycle. Product stewardship is the responsible management of EHS&S

issues such as safe transport, storage, use and disposal.

SOCMA members manufacture thousands of products annually. From pharmaceuticals to cosmetics, soaps to plastics, and all kinds of industrial and construction products, SOCMA members produce the building blocks for materials that save lives, ensure our food supply is safe and abundant, and enable the manufacture of literally thousands of other products. Visit SOCMA's online press room at http://www.socma.com.

ChemStewards(R) is SOCMA's flagship environmental, health, safety and security (EHS&S) continuous performance improvement program. ChemStewards was created from industry's commitment to reducing the environmental footprint left by member facilities. Industry created ChemStewards to meet the unique needs of the batch, custom, and specialty chemical industry. As a mandatory requirement for SOCMA members engaged in the manufacturing or handling of synthetic and organic chemicals, ChemStewards is helping participants reach for superior EHS&S performance through the program's Core Principles. To learn more visit http://www.chemstewards.com.

Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chiral intermediates and specialty resins, primarily for the pharmaceutical industry. Synthetech's products support the development and manufacture of therapeutic peptides and peptidomimetic small molecule drugs at every stage of a customer's clinical development pipeline, and are used in drugs for the treatment of AIDS, cancer, cardiovascular and other diseases.

MORE INFORMATION:

Contact: Deron Neukomm, 541 967-6575

Web site: http://www.synthetech.com

E-mail: investor@synthetech.com


'/>"/>
SOURCE Synthetech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
2. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
3. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
4. Favrille CEO to Present at Bear Stearns Healthcare Conference
5. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
6. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
7. Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference
8. Pharmion Corporation to Present at Bear Stearns 2007 Healthcare Conference
9. Alexion to Present at Bear Stearns Healthcare Conference
10. Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
11. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Florida , February 16, 2017 ... with the infusion of innovative telemedicine application, new ... services that are experiencing a boom worldwide. The ... the advancement of technologies, services and new therapies ... (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced today the ... Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial ... physician suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative ...
(Date:2/16/2017)... 16, 2017  Rhythm, a biopharmaceutical company ... that result in life-threatening metabolic disorders, today ... mezzanine round of financing with existing investors ... New Enterprise Associates, Pfizer Venture Investments, Third ... investment fund. Rhythm will use the proceeds ...
Breaking Biology Technology:
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
Breaking Biology News(10 mins):